Triple Negative Breast Cancer
1 competing product in clinical development for Triple Negative Breast Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eFT508 | eFFECTOR Therapeutics | Phase 2 | Terminated | 44 |
1 competing product in clinical development for Triple Negative Breast Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eFT508 | eFFECTOR Therapeutics | Phase 2 | Terminated | 44 |